Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bob S Carter, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Bob Carter and Jeffrey Schweitzer.
Connection Strength

1.576
  1. Letter to the Editor. Cell therapy for Parkinson's disease. J Neurosurg. 2022 Feb 04; 1-2.
    View in: PubMed
    Score: 0.985
  2. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. N Engl J Med. 2020 05 14; 382(20):1926-1932.
    View in: PubMed
    Score: 0.218
  3. Columnar Injection for Intracerebral Cell Therapy. Oper Neurosurg (Hagerstown). 2020 03 01; 18(3):321-328.
    View in: PubMed
    Score: 0.215
  4. Toward a Personalized Approach to Parkinson's Cell Therapy. Mov Disord. 2020 11; 35(11):2119-2120.
    View in: PubMed
    Score: 0.056
  5. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models. J Clin Invest. 2020 02 03; 130(2):904-920.
    View in: PubMed
    Score: 0.054
  6. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects. Prog Neurobiol. 2018 09; 168:1-20.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.